about
Lessons learned from SARS: the experience of the Health Protection Agency, England.Surveillance and control measures during smallpox outbreaks.Use of a large general practice syndromic surveillance system to monitor the progress of the influenza A(H1N1) pandemic 2009 in the UK.Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatiotemporal analysis of syndromic data.Investigation of food and environmental exposures relating to the epidemiology of Campylobacter coli in humans in Northwest EnglandProvision of services to asylum seekers. Are there lessons from the experience with Kosovan refugees?Changing pattern of human listeriosis, England and Wales, 2001-2004.Social factors associated with increases in tuberculosis notifications.Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.Severe acute respiratory syndrome and Toronto.Community acquired legionnaires' disease: lessons for surveillance from recent outbreaks.The changing epidemiology of cryptosporidiosis in North West England.Enhanced surveillance of campylobacter infection in the North West of England 1997-1999.Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United KingdomValue of syndromic surveillance in monitoring a focal waterborne outbreak due to an unusual Cryptosporidium genotype in Northamptonshire, United Kingdom, June - July 2008Healthcare-associated rotavirus gastroenteritis in a large paediatric hospital in the UKPublic health responses to influenza in care homes: a questionnaire-based study of local Health Protection UnitsSide effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trialHow complete and accurate is meningococcal disease notification?Letters
P50
Q30232915-25C7DB5D-DB72-42DF-8346-A2332751F917Q30233096-B95AC4CF-20FA-4B52-A052-5CD601F41B6DQ30401631-73C22A6B-79FC-4143-8527-B38A53988AC2Q31160578-955F15F6-840E-42FF-BF9E-727B6D61A3FAQ33559495-17E8328A-67CC-4D52-8C54-D347D5EF4AB0Q35407515-9A4B4034-70E5-43A3-9294-7274C820D669Q35805737-C50D4451-CFD0-439C-A40A-25173658F84EQ39501038-0B3092AB-3C26-4394-9B42-C1979AB1DE87Q41131578-4FB5D1F4-1139-478D-8F25-F35B1D4B0712Q42551313-6D72A511-D1A4-4DFA-9A74-08D78787BB72Q43158708-B33668D1-FE96-4F84-87CE-8702E4B56073Q43219194-6D8E8895-0DDB-47FF-9D2A-330676D4D3B9Q54532905-9E53B9C9-47EA-4D07-AAD8-BAB06FFE12ABQ57100935-FB946BC2-6C62-4CE2-96BC-9354E9EC5743Q57313427-D9AB548B-1DA0-48EB-8F14-BFC767E9EC92Q57531042-9B86FE2C-065D-4123-930A-1CB6288965AAQ63865917-0F9D091E-A74E-45B0-AE8D-1143739EA6E7Q77226380-335BD858-7160-41C6-9A39-8C6ED061CF72Q81549702-C020AA9A-1515-405A-A089-7E1E8E0FD376Q93623481-51E89BE1-1F43-4094-9B7D-5A934315A3AA
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2962-9913
@en
name
Martyn Regan
@ast
Martyn Regan
@en
Martyn Regan
@es
Martyn Regan
@nl
type
label
Martyn Regan
@ast
Martyn Regan
@en
Martyn Regan
@es
Martyn Regan
@nl
prefLabel
Martyn Regan
@ast
Martyn Regan
@en
Martyn Regan
@es
Martyn Regan
@nl
P108
P106
P31
P496
0000-0003-2962-9913